IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells

被引:191
作者
Kandere-Grzybowska, K
Letourneau, R
Kempuraj, D
Donelan, J
Poplawski, S
Boucher, W
Athanassiou, A
Theoharides, TC
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[3] Tufts Univ, New England Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA
[4] Tufts Univ, New England Med Ctr, Dept Internal Med, Boston, MA 02111 USA
关键词
D O I
10.4049/jimmunol.171.9.4830
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
FcepsilonRI cross-linkage in mast cells results in release of granule-associated mediators, such as histamine and proteases, as well as the production of numerous cytokines, including IL-6. Mast cells have been increasingly implicated in inflammatory processes where explosive degranulation is not commonly observed. Here, we show that IL-1 stimulates secretion of IL-6 without release of the granule-associated protease tryptase in normal human umbilical cord blood-derived mast cells (hCBMCs). IL-6 secretion stimulated by IL-1 in hCBMCs is potentiated by priming with IL-4 and reflects the higher levels of IL-6 secreted from human leukemic mast cell line (HMC-1). Stimulating HMC-1 cells by both IL-1 and TNF-alpha results in synergistic secretion of IL-6. IL-6 is de novo synthesized, as its secretion is blocked by inhibitors of transcription or protein synthesis. IL-1 does not increase intracellular calcium ion levels in either hCBMCs or HMC-1 cells, and IL-6 stimulation proceeds in the absence of extracellular calcium ions. Ultrastructural Immunogold localization shows that IL-6 is excluded from the secretory granules and is compartmentalized in 40- to 80-nm vesicular structures. Selective secretion of IL-6 from mast cells appears distinct from degranulation and may contribute to the development of inflammation, where the importance of IL-6 has been recognized.
引用
收藏
页码:4830 / 4836
页数:7
相关论文
共 60 条
[11]   ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA [J].
BUTTERFIELD, JH ;
WEILER, D ;
DEWALD, G ;
GLEICH, GJ .
LEUKEMIA RESEARCH, 1988, 12 (04) :345-355
[12]   INFILTRATES OF ACTIVATED MAST-CELLS AT THE SITE OF CORONARY ATHEROMATOUS EROSION OR RUPTURE IN MYOCARDIAL-INFARCTION [J].
CONSTANTINIDES, P .
CIRCULATION, 1995, 92 (05) :1083-1083
[13]   CA2+ RESPONSES TO INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR IN CULTURED HUMAN SKIN FIBROBLASTS - POSSIBLE IMPLICATIONS FOR REYE SYNDROME [J].
CORKEY, BE ;
GESCHWIND, JF ;
DEENEY, JT ;
HALE, DE ;
DOUGLAS, SD ;
KILPATRICK, L .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :778-786
[14]   Sites of interleukin-16 release in patients with acute coronary syndromes and in patients with congestive heart failure [J].
Deliargyris, EN ;
Raymond, RJ ;
Theoharides, TC ;
Boucher, WS ;
Tate, DA ;
Dehmer, GJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09) :913-918
[15]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[16]   CALCIUM AND STIMULUS-SECRETION COUPLING IN MAST-CELL - STIMULANT AND INHIBITORY EFFECTS OF CALCIUM-RICH MEDIA ON EXOCYTOSIS [J].
DOUGLAS, WW ;
KAGAYAMA, M .
JOURNAL OF PHYSIOLOGY-LONDON, 1977, 270 (03) :691-&
[17]   Ultrastructural immunolocalization of basic fibroblast growth factor to lipid bodies and secretory granules in human mast cells [J].
Dvorak, AM ;
Morgan, ES ;
Weller, PF .
HISTOCHEMICAL JOURNAL, 2001, 33 (07) :397-402
[18]   INCREASED ADVENTITIAL MAST-CELLS IN A PATIENT WITH CORONARY SPASM [J].
FORMAN, MB ;
OATES, JA ;
ROBERTSON, D ;
ROBERTSON, RM ;
ROBERTS, LJ ;
VIRMANI, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (18) :1138-1141
[19]   Differential release of mast cell interleukin-6 via c-kit [J].
Gagari, E ;
Tsai, M ;
Lantz, CS ;
Fox, LG ;
Galli, SJ .
BLOOD, 1997, 89 (08) :2654-2663
[20]  
GALLI SJ, 1993, NEW ENGL J MED, V328, P257